Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C49688> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- NCIT_C49688 IAO_0000115 "A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind." @default.
- NCIT_C49688 NCIT_NHC0 "C49688" @default.
- NCIT_C49688 NCIT_P106 "Research Activity" @default.
- NCIT_C49688 NCIT_P108 "Phase IIb Trial" @default.
- NCIT_C49688 NCIT_P207 "C1706096" @default.
- NCIT_C49688 NCIT_P322 "CDISC" @default.
- NCIT_C49688 NCIT_P322 "CDISC-GLOSS" @default.
- NCIT_C49688 NCIT_P325 "Later Phase 2 trials, in transition to Phase 3, where the study populations more closely reflect the population, dosage, and condition for intended use. [Clarification of FDA Guidance for industry end of Phase 2a meetings, September 2009; Discussion in Peter B. Gilbert. SOME DESIGN ISSUES IN PHASE 2B VERSUS PHASE 3 PREVENTION TRIALS FOR TESTING EFFICACY OF PRODUCTS OR CONCEPTS. Stat Med. 2010 May 10; 29(10): 1061-1071.] See also phase, phase 2, phase 2a." @default.
- NCIT_C49688 NCIT_P325 "Later Phase 2 trials, in transition to Phase 3, where the study populations more closely reflect the population, dosage, and condition for intended use. [Clarification of FDA Guidance for industry end of Phase 2a meetings, September 2009; Discussion in Peter B. Gilbert. SOME DESIGN ISSUES IN PHASE 2B VERSUS PHASE 3 PREVENTION TRIALS FOR TESTING EFFICACY OF PRODUCTS OR CONCEPTS. Stat Med. 2010 May 10; 29(10): 1061-1071.]" @default.
- NCIT_C49688 NCIT_P366 "Phase_IIB_Trial" @default.
- NCIT_C49688 normalizedInformationContent "100" @default.
- NCIT_C49688 referenceCount "1" @default.
- NCIT_C49688 hasExactSynonym "2B" @default.
- NCIT_C49688 hasExactSynonym "PHASE IIB TRIAL" @default.
- NCIT_C49688 hasExactSynonym "Phase IIb Trial" @default.
- NCIT_C49688 hasExactSynonym "Trial Phase 2B" @default.
- NCIT_C49688 hasExactSynonym "Trial Phase IIB" @default.
- NCIT_C49688 hasExactSynonym "phase 2b" @default.
- NCIT_C49688 inSubset NCIT_C132298 @default.
- NCIT_C49688 inSubset NCIT_C188693 @default.
- NCIT_C49688 inSubset NCIT_C61410 @default.
- NCIT_C49688 inSubset NCIT_C66737 @default.
- NCIT_C49688 inSubset NCIT_C66830 @default.
- NCIT_C49688 inSubset NCIT_C67497 @default.
- NCIT_C49688 type Class @default.
- NCIT_C49688 isDefinedBy ncit.owl @default.
- NCIT_C49688 label "Phase IIb Trial" @default.
- NCIT_C49688 subClassOf NCIT_C15206 @default.
- NCIT_C49688 subClassOf NCIT_C15429 @default.
- NCIT_C49688 subClassOf NCIT_C15601 @default.
- NCIT_C49688 subClassOf NCIT_C16203 @default.
- NCIT_C49688 subClassOf NCIT_C43431 @default.
- NCIT_C49688 subClassOf NCIT_C49688 @default.
- NCIT_C49688 subClassOf NCIT_C63536 @default.
- NCIT_C49688 subClassOf NCIT_C70820 @default.